While deepening its presence in the North Indian market where it already has a strong presence, the company is looking to scale up in other parts of the country as well.
"Banking on our near leadership in northern India, we are assertively moving into other potentially good geographies, the first of which will be East and Central India where we believe the operation is at an inflection point," Dr Lal PathLabs CEO Om P Manchanda said in a conference call.
"With our investments in regional reference laboratories in Lucknow and a larger one in Kolkata, we are confident that we will be able to fully deploy our hub-and-spoke model to great efficacy," Manchanda said.
As on March 31, 2016, Dr LalPath Labs has 172 clinical labs, including a national reference lab in Delhi, 1,559 patient service centres and 4,967 pick-up points.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
